Ex Parte Morando - Page 8



          Appeal No. 2004-2111                                                        
          Application No. 09/535,550                                                  
          concentration embodiment encompassed by dependent claim 9.  See             
          Atlas Powder Co. v. IRECO Inc., 190 F.3d at 1943, 51 USPQ2d at              
          1945-46.  Similarly, the absence of tantalum in the alloys                  
          disclosed by JP ‘051 fully corresponds to the 0% tantalum                   
          concentration embodiment encompassed by claim 22.                           
               For these reasons and those expressed in the answer, we also           
          determine that the examiner has established a prima facie case of           
          unpatentability which the appellant has failed to successfully              
          rebut with argument or evidence vis-à-vis the section 103                   
          rejection of claims 2, 4-26, 29 and 34 based on JP ‘051.  It                
          follows that we hereby sustain the rejection of these claims as             
          being unpatentable over the aforementioned reference.                       
               For reasons analogous to those discussed above, we are                 
          convinced that the record of this appeal supports a prima facie             
          case of unpatentability with respect to the rejection of claims             
          2, 4-7, 10-16, 18, 20-26, 29 and 34 based on JP ‘673.  We                   
          perceive no merit in the appellant’s argument that claims 16 and            
          18 patentably distinguish over this reference.  This is because             
          the reference expressly discloses vanadium and niobium values               
          (i.e., 3% and 2% respectively) for the alloys thereof which fully           
          correspond to values explicitly recited in these claims.  See               


                                          8                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007